ADARx Pharmaceuticals (ADRX) Insider & Congress Trades

Smart money at a glance

Filings to Nov 13, 2026

Net buying: insiders sold $0 and bought $54.4M on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: +$54.4M net
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Sep 30, 2026: 2 added, 0 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about ADRX filings

Are insiders buying or selling ADARx Pharmaceuticals, Inc. Common Stock (ADRX) stock?

Net buying: insiders sold $0 and bought $54.4M of ADRX stock on the open market in the 90 days to Nov 13, 2026, according to SEC Form 4 filings. The largest was George, Simeon (Director), who bought $27.2M. The latest filing was on Sep 30, 2026.

Which members of Congress have traded ADRX recently?

None. No member of Congress disclosed a ADRX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ADRX smart-money data?

This summary uses filings available on Nov 13, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on ADRX

Lean long2 sources:
- Insiders
- Funds

Top traders
No tracked positions at the last update
Insiders
- LLC Sr One Capital Management, bought $27.2M, open market, filed Sep 30
- Simeon George, bought $27.2M, open market, filed Sep 30
Lean long · thin2 buys · $54.4M
Form 4 filings, open market.
Congress
No recent politician filings found
Funds
- FMR LLC, added, holdings at Sep 30
- BlackRock, added, holdings at Sep 30
Lean long · thin2 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about ADRX filings

Are insiders buying or selling ADARx Pharmaceuticals, Inc. Common Stock (ADRX) stock?

Which members of Congress have traded ADRX recently?

None. No member of Congress disclosed a ADRX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ADRX smart-money data?

Funds

What funds are doing

2 moves · 6 mo

Buys/Adds$119.3M

Buys/Adds (2)

BR
BlackRock
Q3 2026 13F
$46.6M
bought
Signals like this: n=3228, 54% finished lower at D15, median -0.8% vs SPY -0.4%
FM
FMR LLC
Q3 2026 13F
$72.7M
bought

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 12, 2026

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 12, 2026

Period ending

Sep 30, 2026

Earnings per share

Unavailable

EPS comparison unavailable

Revenue

$2.2M

SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 12, 2026	Not on file	No estimate	$2.2MSEC filing	+42.6%from $1.6M
Sep 30, 2025Reported Nov 12, 2026	Not on file	No estimate	$1.6MSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $13.25
High: $16.24
Low: $12.87
Prev close: $13.30
52-wk high: $23.21
52-wk low: $12.50
Mkt cap: $1.47B
ROE: +0.0%
P/S: 240.4x
Profit margin: +0.0%
Op margin: -1735.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.5B

Valuation

P/S240.38

Quality

Operating margin-1735.0%
ROE0.0%
ROA0.0%

Growth

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

34balanced

20D volatility

77%annualized

52-week range

$14.91

$12.50$23.21

20D support

$12.50recent floor

20D resistance

$19.07recent ceiling

Returns

5D +12.2%20D -15.8%

Price vs moving averages

SMA20 -7.7%

Smart money at a glance

Filings to Nov 13, 2026

Net buying: insiders sold $0 and bought $54.4M on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: +$54.4M net
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Sep 30, 2026: 2 added, 0 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about ADRX filings

Are insiders buying or selling ADARx Pharmaceuticals, Inc. Common Stock (ADRX) stock?

Which members of Congress have traded ADRX recently?

None. No member of Congress disclosed a ADRX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ADRX smart-money data?

13F: filed up to 45 days late.

Smart money on ADRX

Lean long2 sources:
- Insiders
- Funds

Top traders
No tracked positions at the last update
Insiders
- LLC Sr One Capital Management, bought $27.2M, open market, filed Sep 30
- Simeon George, bought $27.2M, open market, filed Sep 30
Lean long · thin2 buys · $54.4M
Form 4 filings, open market.
Congress
No recent politician filings found
Funds
- FMR LLC, added, holdings at Sep 30
- BlackRock, added, holdings at Sep 30
Lean long · thin2 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about ADRX filings

Are insiders buying or selling ADARx Pharmaceuticals, Inc. Common Stock (ADRX) stock?

Which members of Congress have traded ADRX recently?

None. No member of Congress disclosed a ADRX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ADRX smart-money data?

Funds

What funds are doing

2 moves · 6 mo

Buys/Adds$119.3M

Buys/Adds (2)

BR
BlackRock
Q3 2026 13F
$46.6M
bought
Signals like this: n=3228, 54% finished lower at D15, median -0.8% vs SPY -0.4%
FM
FMR LLC
Q3 2026 13F
$72.7M
bought

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 12, 2026

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 12, 2026

Period ending

Sep 30, 2026

Earnings per share

Unavailable

EPS comparison unavailable

Revenue

$2.2M

SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 12, 2026	Not on file	No estimate	$2.2MSEC filing	+42.6%from $1.6M
Sep 30, 2025Reported Nov 12, 2026	Not on file	No estimate	$1.6MSEC filing	No year-ago quarter

Open: $13.25
High: $16.24
Low: $12.87
Prev close: $13.30
52-wk high: $23.21
52-wk low: $12.50
Mkt cap: $1.47B
ROE: +0.0%
P/S: 240.4x
Profit margin: +0.0%
Op margin: -1735.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.5B

Valuation

P/S240.38

Quality

Operating margin-1735.0%
ROE0.0%
ROA0.0%

Growth

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

34balanced

20D volatility

77%annualized

52-week range

$14.91

$12.50$23.21

20D support

$12.50recent floor

20D resistance

$19.07recent ceiling

Returns

5D +12.2%20D -15.8%

Price vs moving averages

SMA20 -7.7%

ADARx Pharmaceuticals, Inc. Common Stock

Smart money at a glance

What do analysts expect?

Questions about ADRX filings

Smart money on ADRX

Questions about ADRX filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

ADARx Pharmaceuticals, Inc. Common Stock

Smart money at a glance

What do analysts expect?

Questions about ADRX filings

Smart money on ADRX

Questions about ADRX filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

ADARx Pharmaceuticals, Inc. Common Stock

Overview

Questions about ADRX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

ADARx Pharmaceuticals, Inc. Common Stock

Overview

Questions about ADRX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.